INTERVIEW

INTERVIEW

Interview with Julien Martins & David Philbrick

Julien Martins and David Philbrick talk exclusively with ONdrugDelivery's Guy Furness. They discuss a wide range of topics, including the services Paragon Medical provides the drug delivery industry, its wider business operations, the company’s expanded facilities in the US and Europe, and its new Advanced Surgical Innovation Center.

INTERVIEW

CONNECTING PHARMA: INSIGHTS FROM AUTOMOTIVE INDUSTRY EXPERIENCE

Jim McGough talks with Guy Furness about the current state and future of connectivity in drug delivery and pharma more broadly. In an enlightening discussion, Mr McGough shares insights from his time pioneering connectivity in the automotive industry at Volkswagen Group and how those lessons might apply to pharma, as well as considering what might be holding the industry back from going full steam ahead on connectivity and how that might change over the next decade.

INTERVIEW

Arnaud Guillet

Biocorp

Interview with Arnaud Guillet & Fanny Sellier

Arnaud Guillet and Fanny Sellier talk with Guy Furness about how Biocorp has become a key player in the field of connected drug delivery, discuss the current landscape for connectivity in drug delivery and update us on its two major parenteral products – Mallya and Injay – as well as looking forward to the launch of the company’s next generation of connected drug delivery solutions.

INTERVIEW

Julien Storz

Aptar Pharma

WHY SUSTAINABLE PACKAGING MATTERS IN PHARMA’S CIRCULAR APPROACH – APTAR PHARMA’S FUTURITY PLATFORM LEADS THE WAY

Julien Storz discusses the importance of sustainable packaging in the pharma industry and introduces the company’s Futurity platform and its role in product circularity.

INTERVIEW

Dr Stefan Hellbardt

Aptar Pharma

DE-RISKING COMBINATION PRODUCT REGISTRATION FOR SEMI-SOLIDS WITH APTAR PHARMA’S AIRLESS⁺ SYSTEM – AN INTERVIEW WITH STEFAN HELLBARDT

Stefan Hellbardt discusses the increasing demand for airless systems in the dermal drug delivery market, the advantages of these systems and Aptar Pharma’s own offering in this space, including its Airless+ packaging system and Extended Support services.

INTERVIEW

Guy Furness

Kymanox

Interview: Kymanox Executive Advisors Mathias Romacker, Fran DeGrazio & Paul Jansen

Mathias Romacker, Fran DeGrazio and Paul Jansen sit down with Guy Furness, to discuss what it is that has driven Kymanox’s rapid rise in the drug delivery space and what makes the consulting company’s model so successful, as well as to share their expertise on a variety of topics in an illuminating discussion, including connectivity, how large and small drug developers engage with consultancies, 5 mL autoinjectors and the interface between drug primary packaging and delivery devices.

INTERVIEW

Guy Furness

Aptar Pharma

Interview: Gabriel Zenker, Aptar Pharma

Gabriel Zenker talks with ONdrugDelivery about Aptar Pharma’s ambitions for the parenterals sector. Mr Zenker explains how Aptar, already a major player in the pulmonary, nasal, ophthalmic and dermal markets, is undertaking a major expansion of its facilities, boosting the company’s capacity, capabilities and technologies, to provide its extensive service and product offering to the exciting injectables space.

INTERVIEW

Dr Ben Cox

Team Consulting

Pharmapack Expert Panel on Patient-Centric Digital Health: Interview with Ben Cox, Team Consulting

With Pharmapack returning to its traditional February timing in 2023, Team Consulting will be chairing a Day 1 expert panel discussion on patient-centric digital health solutions. Interviewed here, Ben Cox provides insight into trends the panel will discuss, lays out the current status of the industry with respect to digital health and considers what to look forward to at Pharmapack this year.

INTERVIEW

Dr Oliver Eden

Jabil Healthcare

Connected Drug Delivery – Is the Near-Term Opportunity in Clinical Development? – an Interview with Oliver Eden

Oliver Eden of Jabil Healthcare looks at the factors influencing the return on investment metrics in clinical development and introduces Jabil’s autoinjector platform Qfinity™ and its connected version, Qfinity+™.

INTERVIEW

Arnaud Guillet

Biocorp

Interview with Biocorp’s Arnaud Guillet

In this exclusive interview, Arnaud Guillet of Biocorp talks with ONdrugDelivery about connectivity in the injectables space, sharing some of the insights Biocorp has gained from its decade of experience in developing connected drug delivery devices.

INTERVIEW

Renan Joel

INTERVIEW: RENAN JOEL, CONNECT IN PHARMA CONFERENCE

Renan Joel, Easyfairs' Divisional Director Packaging – UK, France, Italy & Switzerland, talks with ONdrugDelivery about the upcoming inaugural Connect in Pharma conference in Geneva.

INTERVIEW

Piyush Agarwal

INTERVIEW: Piyush Agarwal, Tjoapack

Piyush Agarwal talks with ONdrugDelivery about the current state of the injectable pharmaceuticals market and how working with a specialist contract packaging organisation can help pharma companies navigate their product through this rapidly evolving sector and deliver their product to market on time.

INTERVIEW

Steven Kaufman

Stevanato Group

INTERVIEW: STEVEN KAUFMAN, STEVANATO GROUP, & MICHAEL EARL, OWEN MUMFORD

In this exclusive interview, Steven Kaufman of Stevanato Group, and Michael Earl of Owen Mumford, talked with us about their companies' recent major agreement for the manufacturing and provision of prefillable syringes for the advanced two-step, single-use autoinjector, Aidaptus^®.

INTERVIEW

Aurelio Arias

INTERVIEW: AURELIO ARIAS, IQVIA

Aurelio Arias of IQVIA discusses trends in the drug delivery industry, including how device and packaging manufacturers are increasingly aligning as strategic partners to speed innovation and reduce reliance on pharma investment.

INTERVIEW

Dr Jon Lenn

MedPharm

INTERVIEW: JON LENN & JON VOLMER, MEDPHARM

Jon Lenn and Jon Volmer talked with Guy Furness about the importance of nasal modelling, focusing on MedPharm’s own nasal cavity modelling technology, MedCast, its unique characteristics and benefits and the value it brings to the company’s offering for nasally delivered products.

INTERVIEW

Natalia Servol

Unither Pharmaceuticals

INTERVIEW: Natalia Servol, Unither Pharmaceuticals

In this interview, Natalia Servol, Head of Unither Pharmaceuticals’ Ophthalmic Business, speaks about the company's equipment for compounding and fill-finish of preservative-free products into multidose bottles, part of Unither’s unique and innovative preservative-free multidose offering for partners.

INTERVIEW

Arnaud Guillet

Biocorp

Interview: Arnaud Guillet, Biocorp

In this exclusive interview with ONdrugDelivery, Arnaud Guillet discusses Mallya, Biocorp’s connected clip-on for pen injectors, including Mallya’s successful launch in multiple countries this year, the factors that have played into the device’s success, and the future for Mallya, Biocorp and connectivity in the drug delivery industry.

ROUNDTABLE

Frédérique Bordes-Picard

Lonza

ROUNDTABLE: CAPSULE-BASED DRY POWDER INHALERS

Frédérique Bordes-Picard of Lonza, Marco Franza of Berry, Mirjam Kobler of Meggle, and Marco Laackmann of Harro Höfliger, discuss the accelerating development potential of capsule-based dry powder inhalers (DPIs) and the potential of these effective and efficient drug delivery devices in the modern drug delivery market.

ROUNDTABLE

Sebastian Gerner

Alliance to Zero

ROUNDTABLE: ALLIANCE TO ZERO

Sebastian Gerner, Robert O’Beirn and Sabrina Gérard talk with ONdrugDelivery about the Alliance to Zero, an association for pharma and biotech supply chain companies that aims to facilitate the transition of the pharma sector to compliance with net-zero emissions.

INTERVIEW

Mathias Romacker

INTERVIEW WITH MATHIAS ROMACKER, EX-PFIZER, INJECTION DEVICES STRATEGY CONSULTANT

In this exclusive interview, Mathias Romacker discusses a broad range of topics, from his professional expertise and history seeing the parenteral sector evolve first-hand, to his personal experience as a Crohn’s disease patient making use of the very devices he’s seen grow and develop.

INTERVIEW

Stephen Perry

Kymanox

INTERVIEW WITH STEPHEN M PERRY AND NICHOLAS CICCARELLI

Stephen Perry and Nicholas Ciccarelli discuss the August 2021 acquisition of Neuma by Kymanox, highlighting how the acquisition has positioned Kymanox to lead the development of particularly complex drug delivery systems and cutting-edge medical device technologies, providing additional services to progress combination products to market.

INTERVIEW

Benjamin Dietiker

Weidmann Medical Technology

INTERVIEW WITH BENJAMIN DIETIKER, WEIDMANN MEDICAL TECHNOLOGY

Benjamin Dietiker, Weidmann Medical Technology, talks with ONdrugDelivery about how the company has successfully implemented a growth strategy by focusing on key areas, plans for expansion, the effect of covid-19 on the business, and how the company differentiates itself from larger competitors by focusing on quality and service.

INTERVIEW

Steve Amoussou-Guenou

Roquette

INTERVIEW WITH STEVE AMOUSSOU-GUENOU, ROQUETTE

In this interview, Steve Amoussou-Guenou discusses how Roquette developed the LYCAGEL™ system and how this plant-based alternative compares with traditional gelatin softgel capsules.

INTERVIEW

Erik Haeffler

Recipharm

INTERVIEW: ERIK HAEFFLER, RECIPHARM

In this interview, Erik Haeffler discusses how the pharma industry can balance optimising environmental sustainability with maintaining the highest safety and efficacy standard for achieving its main objective of promoting patient health and wellbeing.

INTERVIEW

Dr Andrei Yosef

Eitan Medical

ANDREI YOSEF, CEO, SORREL MEDICAL

In this exclusive interview, Andrei Yosef discusses Sorrel’s differentiated electro-mechanical, connected wearable injection platform, and two exciting recent milestones for the company, the opening of a state-of-the-art manufacturing facility and the signing of a significant partnership with a large pharma company.

INTERVIEW

Aaron Mann

INTERVIEW WITH AARON MANN, CHIEF EXECUTIVE OFFICER, KINDEVA

In this exclusive interview with ONdrugDelivery, Aaron Mann discusses how Kindeva is positioned to move forward as a major CDMO specialising in inhalation and transdermal dosage forms, having been formed from 3M’s drug delivery in May 2020. We also cover the impact of Covid-19, environmental sustainability, and current challenges faced by the pharmaceutical industry.

ROUNDTABLE

Dr Jeremy Drummond

ROUNDTABLE: JEREMY DRUMMOND, MEDPHARM; STEPHEN RODE, LONZA; AND TORKEL GREN, RECIPHARM

In this roundtable discussion, Jeremy Drummond, Stephen Rode and Torkel Gren discuss trends with different drug dosage forms for different routes of administration, the rise of patient centricity including the shift from the blockbuster model to more tailored products.

INTERVIEW

Maria Flynn

Adare Pharma Solutions

INTERVIEW WITH MARIA FLYNN, ADARE PHARMACEUTICALS

Adare Pharma's Maria Flynn talks with ONdrugDelivery about trends in the oral drug development and delivery space, completing the Orbis Biosciences acquisition during a global pandemic, and how the excellent technology portfolio and strategic fit between Orbis and Adare form part of the combined organisation’s unique story.

INTERVIEW

Milena Batalla

Panarum

INTERVIEW WITH MILENA BATALLA, PHD, PANARUM

Dr Batalla introduces the company and describes its Proteoral^® technology for the oral delivery of proteins to the bloodstream, therapeutic applications, and products to date. Panarum is an Argentine company and this interview is presented here in Spanish and English, an exciting first for ONdrugDelivery!

INTERVIEW

Sai Shankar

Aptar Pharma

INTERVIEW WITH SAI SHANKAR, ADAM SHAIN & MARCUS BATES

Sai Shankar, Adam Shain and Marcus Bates discuss the full potential of connectivity, coronavirus as a potential accelerator of adoption, and the place of connected drug delivery systems within Aptar Pharma’s broader offering to industry.

INTERVIEW

Steven Kaufman

Stevanato Group

INTERVIEW WITH STEVEN KAUFMAN, STEVANATO & URI BARUCH, CDP

Steven Kaufman and Uri Baruch discuss the recently announced collaboration between their two companies to accelerate the development of a new variable-dose, cartridge-based pen injector platform for diabetes.

INTERVIEW

Dr Gautam N Shetty

Congruence Medical Solutions

INTERVIEW WITH DR SRI MUDUMBA, SANTEN & DR GAUTAM SHETTY, CONGRUENCE

In this interview, Dr Sri Mudumba, Santen, and Dr Gautam N Shetty, Congruence Medical Solutions, share insights from their experience of working together in developing the MDS for ophthalmic injections.

INTERVIEW

Cecile Halte

BD (Becton Dickinson & Company)

Cecile Halte, BD

In this interview, Cécile Halté, Senior Program Manager, Acute Care Segment, for BD Medical – Pharmaceutical Systems. discusses validation studies of the BD Sterifill Advance™ plastic prefilled syringe, which is intended for use in the hospital setting by healthcare professionals either for manual bolus injections, or with infusion pumps.

INTERVIEW

Bob Tilling

Bob Tilling, Kallik

In this interview, Bob Tilling, Business Development Manager at Kallik, shares his insights on best practice for factory labelling.

CONNECTIVITY

Eric Dessertenne

Biocorp

COMPLETING ITS TRANSITION FROM GENESIS TO MATURITY, BIOCORP OPENS NEW HORIZONS

As Biocorp prepares for the market launch of its connected injector pen add-on, Mallya, Eric Dessertenne and Arnaud Guillet share insights about key steps in the company’s development. The article discusses the many partnership Biocorp has entered in to, and includes a mini-interview with Sergio Monti, Plant Manager for one such partner, V.A.R.I.

INTERVIEW

Dr Mircea Despa

BD (Becton Dickinson & Company)

MIRCEA DESPA & DOUG McCLURE, BD

In this interview, Dr Despa and Mr McClure discuss BD’s approach to connecting devices in its portfolio to meet patient, pharma and other stakeholder requirements. Their discussion focuses in particular on safety and security, highlighting the connected wearable injector, BD Libertas™ with Smart Option, as an example.

INTERVIEW

Guillaume Brouet

Aptar Pharma

GUILLAUME BROUET, APTAR PHARMA

Guillaume Brouet talks with ONdrugDelivery Magazine about how Aptar Pharma uses its device development expertise and infrastructure to provide its pharmaceutical company customers a comprehensive services offering around device development, global regulatory approval and commercialisation.

INTERVIEW

Paul Allsop

Bespak by Recipharm

PAUL ALLSOP, MILES KOTTMAN, HANNAH PRIESTLY & JON REED, CONSORT GROUP

Consort Medical's Paul Allsop, Miles Kottman, Hannah Priestly and Jon Reed talk with ONdrugDelivery Magazine about the company’s integrated formulation and device offering, and focus on its simple, low-cost, single unit-dose, spring powered nasal device, Unidose Xtra.